The Addiction Psychologist

On this Addiction Psychologist segment, we talk to experts about new policy developments to get a better understanding of the implications for our work, our clients, and our personal lives. On this episode, we talk with Dr. Lara Coughlin about the science of contingency management, recent changes in incentive allowance for contingency management, and how these changes might impact practice. Dr. Lara Coughlin is an assistant professor in the University of Michigan Addiction Center and Department of Psychiatry at the University of Michigan Medical School, as well as the Director of the CHOICE lab, the Co-director of the Michigan Innovations in Addiction Care through Research and Education Program and the Faculty Lead of Mental Health Equity at the University of Michigan Eisenburg Family Depression Center. Learn more about contingency management here, and about the changes to allowable incentives here.

Although risk of substance use disorder exists for anyone that uses substances, study after study shows that early initiation of substance use in adolescence is a strong predictor of later substance-related problems and is associated with higher risk . What is going on in the brain during adolescence, and how do substances affect it? Dr. Lindsay Squeglia discusses the development of the brain during adolescence and the risks of substance use during adolescence, and attempts to answer our questions about the chicken or the egg. Dr. Squeglia also talks about her efforts to create evidence-based psychoeducation programs about substance use for adolescents and programs to help teens get involved in science. Dr. Lindsay Squeglia is a Professor of psychiatry and behavioral sciences in the College of Medicine at the Medical University of South Carolina, and a Co-Director of the MUSC Youth Collaborative. Find out more about her work here.

Alcohol is often consumed around others: at bars or clubs, social events, college parties, or dinner with friends. How does alcohol influence social connection, and vis-a-versa? Why are they so seemingly interconnected? In this episode, Dr. Michael Sayette discusses his research on alcohol's relationship with the social context and the clinical importance of understanding how the acute effects of alcohol influence social connection. Dr. Sayette is a Distinguished Professor in the Department of Psychology at the University of Pittsburgh. You can learn more about his work here.

Alcohol impairs motor activity and cognitive functioning that is critical for effective and safe driving, increasing risk of accident. In fact, approximately 1/3 of all traffic fatalities are alcohol-related. Why do some people drive after drinking despite these risks? Dr. Denis McCarthy discusses the history of impaired driving and policy, theories of impaired driving-related decision making, and pathways to prevention, intervention, and treatment. Dr. McCarthy also discusses cannabis-impaired driving and important distinctions between cannabis and alcohol. Dr. Denis McCarthy is the Middlebush Professor of Psychology at the University of Missouri. Learn more about his work here.

In recent years, there has been a dramatic rise in methamphetamine use among people who use opioids. What is driving this effect? How do these drugs interact? Do they serve substitute or complementary functions? Dr. Justin Strickland summarizes the state of the science and outlines potential solutions. Dr. Strickland is a psychologist and assistant professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. You can learn more about his work here.

For many, the onset of substance use occurs in adolescence. A subset of adolescents who use substances develop substance use disorders later in life, and some even develop harmful patterns of drinking while still in the developmental stage of adolescence. Why is substance use initiation likely in this age group, and what is the developmental function of substance use behavior? What are the interpersonal processes that influence substance use, and how do relationships with friends and family change during this critical developmental stage? Is it possible to leverage these interpersonal processes to bolster treatment initiation and success? Dr. Sam Meisel answers these questions and more as he discusses the complex social environment of the adolescent and it's pertinence to understanding substance use. Dr. Sam Meisel is a Research Scientist at Bradley Hospital and the Center for Alcohol and Addiction Studies in the Brown University School of Public Health.

Sleep is a critical function that can be disrupted by substance use. In fact, the majority of people with an alcohol use disorder report insomnia or sleep disturbance. So, what is good sleep, and why does it seem that substance use disrupts it? Can you treat the sleep, even if the drinking doesn't change? Does cannabis actually help sleep? Dr. Mary Beth Miller answers these questions and more, in our latest episode on the relationship between sleep and substance use. Dr. Mary Beth Miller is an Assistant Professor in the Department of Psychiatry at the University of Missouri School of Medicine.

On this new Addiction Psychologist segment, we talk to experts about new policy developments to get a better understanding of the implications for our work, our clients, and our personal lives. On this episode, we talk with Dr. Adam Leventhal about the October 12, 2021 announcement that the FDA has authorized the marketing of three new tobacco products, marking the first set of electronic nicotine delivery system (ENDS) products ever to be authorized by the FDA through the Premarket Tobacco Product Application (PMTA) pathway. Dr. Adam Leventhal is a Professor in the Department of Preventive Medicine and Psychology in the Keck School of Medicine at the University of Southern California and a member of the Tobacco Products Scientific Advisory Committee for the Food and Drug Administration. You can read the full FDA press release here. In the days after the recording of this episode, the FDA made a similar announcement authorizing several oral tobacco products, suggesting that authorizations may occur at a rapid pace in the coming weeks.